Clinical Trial Update: Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients. [NA]

View source ↗

Summary

A completed clinical trial from Yonsei University examined how genetic variants in CYP2C9 and CYP2C19 affect phenobarbital pharmacokinetics in Korean neonates w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Seizures

Drugs mentioned

• Phenobarbital (phenobarbital)

Snippet

Sponsor: Yonsei University | Conditions: Neonatal Seizure | NA | Status: COMPLETED